Featured
The Villages Health settles $541.5M Medicare case
Trial Moves Aug 30, 2026
Patient Briefs Aug 29, 2026
Trial Moves Aug 28, 2026
Penalties for healthcare info blockers take effect to ensure access to electronic health information, promoting...
UnitedHealthcare CEO murdered by gunman Luigi Mangione who confessed to the crime in federal court,...
Understanding reading comprehension through research on human and AI language processing to improve reading skills...
Read our latest NF Research articles.
Costco partners with SCAN Health Plan to offer new Medicare Advantage plans in two states...
Circumcision does not increase autism risk in boys, a new study on circumcision and autism...
Scientists discover plant fullness mechanism to reduce fertilizer use with a key protein linked to...
Bispecific antibodies are emerging immunotherapy for relapsed lymphoma and leukemia, offering a viable option when CAR T‑cell treatment isn’t possible, with car
Bispecific antibodies are emerging immunotherapy for relapsed lymphoma and leukemia, offering a viable option when CAR T‑cell treatment isn’t possible,...
Bispecific therapy program by American Oncology Network offers safe outpatient dosing guidelines for community clinics, ensuring close monitoring and patient...
Heart failure management is shifting as pharmacists take on a larger role. Discover how they are improving outcomes for patients...
Proton pump inhibitors may reduce the benefit of durvalumab consolidation after chemoradiotherapy for unresectable stage 3 NSCLC, according to a...
GLP-1 receptor agonists can interact with oral chemotherapy, jeopardizing treatment effectiveness for diabetes and weight loss patients using glp-1 agents.
President Trump directs CMS to allocate $10 billion for rural health transformation under the One Big Beautiful Bill Act of...
New data on schizophrenia treatment options with subcutaneous olanzapine formulation show promise for people with schizophrenia.
Medicare introduces a $50 monthly copay for GLP-1 weight-loss drugs, offering affordable access to eligible beneficiaries starting July 2026.
FDA approves Leqembi home administration. Learn about the new starting dosage regimen for subcutaneous lecanemab treatment.
Explore the 2026 pulmonary embolism guidelines released by the American Heart Association and ACC, detailing severity categories and treatment strategies...